Location: Home
  • search
  • go
  • Relate News
  • 12/26/2022NHSA Announces Comprehensive Inspection of Irregular BMI Coverage Rest...
  • 12/26/2022Hikma and Junshi Sign Exclusive Licensing Pact for Anticancer Toripali...
  • 12/26/2022Deloitte: 2023 China LSHC Investment and M&A Market Outlook
  • 12/26/2022Two Large Out-licensing Deals Edge November Deal Values to Over $2.9B ...
  • 12/23/2022Beijing's Covid Wave May Have Peaked But China's Tsunami of Cases Is M...
  • 12/23/2022Eisai Initiates BLA Filing for Alzheimer's Drug Lecanemab in China
  • 12/23/2022Drug R&D and Product Registration News Digest December 2022 (3)
  • 12/22/2022Merck and Kelun Ink Exclusive License Pact for Seven Investigational ...
  • 12/22/2022NHSA: Further Reduction of Drug and Medical Consumable Prices to Secur...
  • 12/22/2022NMPA and Chinese Customs Issues the Announcement for Regulation of Imp...
  • 12/22/2022CDE Issues Two New Guidelines for Clinical Evaluation of New TCMs
  • 12/22/2022CDE Seeks Public Comments on the Technical Guidelines for Immunogenic ...
  • 12/22/2022CDE Seeks Public Comments on the Technical Guidelines for Clinical Tri...
  • 12/21/2022NMPA Solicits Comments on the Guidelines for the Study of Disease Natu...
  • 12/21/2022Shanghai Looks to Turn Pharmacies into Healthcare Service Providers
  • 12/21/2022XtalPi and EDDC Partner in AI-empowered Drug Discovery Program for NSC...
  • 12/21/2022BioNTech Sends First Batch of Vaccine to China for German Residents Th...
  • 12/20/2022Chinese Pharmacopoeia Commission Publishes the Compilation Guidelines ...
  • 12/19/2022Pfizer Opts In to LianBio Rights to RSV Candidate Sisunatovir in Great...
  • 12/19/2022NMPA Hosts BRICS Drug Regulatory Authorities Meeting via Videoconferen...
  • 12/19/2022Adagene Announces Clinical Trial Collaboration to Evaluate Anti-CTLA-4...
  • 12/19/2022GenFleet and Merck Enter into Trial Collaboration to Initiate Study In...
  • 12/19/2022U.S., China Advance Discussions On Pact To Accelerate Cancer Drug Tria...
  • 12/16/2022Laekna's Afuresertib Competes with Roche and AZ in AKT (PharmaDJ)
  • 12/16/2022Small Molecule Approvals for Rare Diseases in China Reach All-time Hig...
  • 12/16/2022Recent Executive Moves
  • 12/16/2022Drug R&D and Product Registration News Digest December 2022 (2)
  • 12/15/2022China's Drug Non-Clinical Safety Evaluation Research Institution Infor...
  • 12/15/2022Key Chinese Antimonopoly Regulator at SAMR under Investigation
  • 12/15/2022Wuxi Biologics Removed from U.S. Unverified List
  • Page:151/808 Total number of articles:24233: [First][<<] [149] [150] [151] [152] [153] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group